openPR Logo
Press release

Anaphylaxis Treatment Market – Analysis On Current Trends by 2028 | Impax Laboratories Inc., Lincoln Medical Ltd., Mylan N.V., Adamis Pharmaceutical Corporation, MannKind Corporation, Pfizer Inc., GlaxoSmithKline Plc., Merck & Co., Inc., Teva Pharmaceut

07-03-2019 04:25 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Anaphylaxis Treatment Market – Analysis On Current Trends

The type of severe allergic reaction which may cause due to food, insect bites, latex or medications is known as anaphylaxis. Anaphylaxis is fast in the beginning and cause serious health problems and sometimes death. The symptoms of anaphylaxis include itchy rashes, vomiting, breath shortness, tongue or throat swelling, low blood pressure, and lightheadedness. These all symptoms may last for a minute to an hour and may typically come on over and over again. The mechanism comprises of the release of mediators by either non-immunologic or immunologic mechanism from certain types of white blood cells activated. The primary anaphylaxis treatment includes epinephrine, steroids, and antihistamines through an oral or parenteral route of transmission. An additional dosage of epinephrine may require in some cases. Approximately 2% of the world population is expected to experience anaphylaxis at some point in life, globally. Worldwide the rates of anaphylaxis are increasing and mostly occurs in young population and females. In the United States, the percentage of the population admitted in the hospitals is very high and increasing and around 0.3% of the population die due to anaphylaxis.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=3417

Anaphylaxis Treatment: Market Dynamics

The increasing incidence of anaphylaxis globally is the main driving factor for the growth of the anaphylaxis treatment market. Additionally, innovative novel product launches by the major manufacturers contributing to the market growth of the anaphylaxis treatment market. For eg: in November 2018, Teva Pharmaceuticals, Inc. received FDA approval for epinephrine an auto-injector. It is the first generic equivalent to EpiPen, an emergency injectable anaphylaxis treatment. Increasing awareness regarding available anaphylaxis treatment options among patients and healthcare professionals are the boosting factors for the growth of the anaphylaxis treatment market. However, anaphylaxis treatment cost, lack of awareness in developing regions about the allergies and anaphylaxis treatment hampering the growth of anaphylaxis market. Moreover, side effects related to drugs used in the anaphylaxis treatment is expected to hinder the growth of the anaphylaxis treatment market.

Anaphylaxis Treatment market: Segmentation

The global Anaphylaxis Treatment market is segmented by medication type, route of administration, allergy type, distribution channel and regions:

Anaphylaxis Treatment Segmentation by Medication Type
Epinephrine
Antihistamines
Steroids
Beta-Agonist
H2 blockers
Vasodilators
Others
Anaphylaxis Treatment Segmentation by Route of Administration
Oral
Parenteral
Others
Anaphylaxis Treatment Segmentation by Allergy Type
Food Allergy
Medications
Insect Stings
Latex Allergy
Others
Anaphylaxis Treatment Segmentation by Distribution Channel
Hospital Pharmacies
Retail Sales
Drug Store
Mail Order Pharmacies
Others
Anaphylaxis Treatment market: Overview

Anaphylaxis is a very serious allergic reaction that needs to be treated as soon as possible. The introduction of auto-injectors for the anaphylaxis treatment act as the revolutionary medications for the anaphylaxis treatment. Additionally, manufacturer more focusing on delivering and expanding in the untapped market for expanding their revenue generation. Manufacturer delivering the low-cost generic version of drugs used for the anaphylaxis treatment such as Mylan N.V. has introduced EpiPen generic version at half price. Until 2016 it was sold at US$ 600 which was reduced to the price of US$ 300 in 2017. However, there are a large number of the patient which is underserved due to low medical facilities and unaware of the anaphylaxis reactions and treatments which may hamper the anaphylaxis treatment market growth.

Ask For Customized Report @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=3417

Anaphylaxis Treatment market: Region-wise Outlook

The anaphylaxis treatment market in North America will show the high market growth in the global anaphylaxis treatment market due to rising anaphylaxis incidence, changing lifestyle and advanced healthcare infrastructure. Additionally, increasing awareness and availability of anaphylaxis treatment is boosting the market, followed by Europe. The anaphylaxis treatment market in the Asia-Pacific region will show moderate growth due to high negligence rate for anaphylaxis conditions and large underserved patients. Whereas, Latin America and the Middle East & Africa are expected to show constant anaphylaxis treatment market growth due to weak healthcare infrastructure and low awareness for anaphylaxis.

Anaphylaxis Treatment market: Key Players

Some of the key players present in global anaphylaxis treatment market are Impax Laboratories Inc., Lincoln Medical Ltd., Mylan N.V., Adamis Pharmaceutical Corporation, MannKind Corporation, Pfizer Inc., GlaxoSmithKline Plc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., ALK-Abelló, and others.

The report covers exhaustive analysis on:

Anaphylaxis Treatment Market Segments
Anaphylaxis Treatment Market Dynamics
Anaphylaxis Treatment Market Size
Current Trends/Issues/Challenges
Competition & Companies involved
Value Chain
The regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
The Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
The Middle East and Africa (GCC, S. Africa, N. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance

For more information on this report, please visit: https://www.factmr.com/report/3417/anaphylaxis-treatment-market

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anaphylaxis Treatment Market – Analysis On Current Trends by 2028 | Impax Laboratories Inc., Lincoln Medical Ltd., Mylan N.V., Adamis Pharmaceutical Corporation, MannKind Corporation, Pfizer Inc., GlaxoSmithKline Plc., Merck & Co., Inc., Teva Pharmaceut here

News-ID: 1795567 • Views: 133

More Releases from Fact.MR

Introduction of Bio-based Coating Additives Likely to Navigate Future Sales, det …
Albany, New York, November 21, 2019: Fact.MR has recently updated a new study which comprehensively details about the expected trends and opportunities set to influence the global market for coating additives. Furthermore, the launch of green coatings is positively steering the coating additives market to enter a new phase. In the near future, the application of green coatings is likely to gain high-end popularity within the automotive industry, thereby, enhancing
11-20-2019 | Health & Medicine
Fact.MR
Dog and Cat Ownership are Primary Contributors to Growth of Animal Parasiticides …
Animal parasiticides are materials that are key ingredients in medicines that are used for veterinary purposes. These agents specialize in helping the health of animals and livestock, by killing parasites including microbial forms such as fungi and bacteria. The global market for animal parasiticides are expected to grow at a strong CAGR of over 6 per cent through the forecast period till 2026. This rapid rise is largely attributed to the
11-19-2019 | Health & Medicine
Fact.MR
Advances in Artificial Insemination to Play Substantial Role in Increasing Oppor …
Animal genetics is a branch in the field of genetics that are primarily involved with the study of gene variation for wild and domestic animals, which includes aspects such as animal breeding, gene expression, and physical genetic traits. Activities in the field involve genetic disease traiting, DNA testing, and genetic trait testing among others. The global animal genetics market is projected to grow at a strong CAGR of over 6 per
Ready Meal Trays’ Myriad Applications and Recyclability Spearheading the Food …
The ready meal trays market continues to showcase stunning prospects, with overall incremental opportunity of over US$ 1.7 Billion by 2027 from 2019, according to a recent Fact.MR study. Growth in consumption of packaged food products across both developed as well as developing countries is anticipated to increase the demand for ready meal trays during the forecast period. Ready meal trays are increasingly used by food processors and fast service

All 5 Releases


More Releases for Anaphylaxis

Anaphylaxis Treatment Market Segments And Key Trends 2018 to 2028(Anaphylaxis Tr …
The type of severe allergic reaction which may cause due to food, insect bites, latex or medications is known as anaphylaxis. Anaphylaxis is fast in the beginning and cause serious health problems and sometimes death. The symptoms of anaphylaxis include itchy rashes, vomiting, breath shortness, tongue or throat swelling, low blood pressure, and lightheadedness. These all symptoms may last for a minute to an hour and may typically come on
Anaphylaxis Treatment Market | Research Report | Forecast 2018 to 2024
The Growth Of Anaphylaxis Treatment Market And Introduction To Auto-Injectors In The Global Market Anaphylaxis is a serious, allergic reaction that is to be treated immediately. Anaphylaxis is a life-threatening reaction with cardiovascular, respiratory, gastrointestinal, or cutaneous manifestations resulting from exposure to an offending agent, usually insect sting, food, physical factor, or medication. It is typical causes more than one of the symptoms such as throat or tongue swelling, itchy
Anaphylaxis Market worth $40 billion by 2024
Latest report on United States Anaphylaxis Market of 180 pages now added by a leading business intelligence provider to ReportsnReports.com database. Access Full Report with Table of Contents @ https://www.reportsnreports.com/reports/1820038-united-states-anaphylaxis-market-food-reaction-testing-by-food-sources-treatment-services-age-group-urban-rural-end-users.html. Anaphylaxis or Anaphylactic reaction is a very rare type of reaction which is caused by Foods, Medicines, Insect strings, Latex etc. In this report, we have studied the Anaphylaxis reaction to foods. Anaphylaxis food reaction is a life threatening allergy
United States Anaphylaxis Market: Surged Adoption of Novel Therapeutics Such as …
Onward rise in incidences of anaphylactic reaction in United States triggered by host of factors such as foods and drugs often resulting in fatality has augmented advancements in anaphylaxis therapeutics in recent years. Ongoing progress in novel treatment and diagnosis services are likely to prompt growth in United States anaphylaxis market. Aforementioned market insights along with other valuable market highlights have been divulged in a new market intelligence report titled, 'United
US Anaphylaxis Food Reaction Testing Market will be more than US$ 40 Million by …
Access full Research: https://www.renub.com/us-anaphylaxis-market-p.php Get Free Customization in This Report Anaphylaxis or Anaphylactic reaction is a very rare type of reaction which is caused by Foods, Medicines, Insect strings, Latex etc. In this report, we have studied the Anaphylaxis reaction to foods. Anaphylaxis food reaction is a life threatening allergy which can cause death if the prior administration would not be taken. United States Anaphylaxis Food Reaction Testing Market will be
Anaphylaxis Treatment Market: The Growth Of Anaphylaxis Treatment Market And Int …
Anaphylaxis Treatment Market Anaphylaxis is a serious, allergic reaction that is to be treated immediately. Anaphylaxis is a life-threatening reaction with cardiovascular, respiratory, gastrointestinal, or cutaneous manifestations resulting from exposure to an offending agent, usually insect sting, food, physical factor, or medication. It is typical causes more than one of the symptoms such as throat or tongue swelling, itchy rash, vomiting, shortness of breath, light-headedness, and low blood pressure. Global Anaphylaxis